Treatment and Visual Outcomes of patients with Punctate Inner Choroidopathy
Author: Sheema Khan (United Kingdom)
Co-authors: Sheema Khan, Clara McAvoy
Purpose
To document the demographics, clinical findings, management, complications and visual outcomes of patients with Punctate Inner Choroidopathy (PIC) presenting to the Uveitis clinic at Belfast Health and Social Care Trust
Setting/Venue
Uveitis Clinic.
Methods
A retrospective electronic chart review of a series of patients with a diagnosis of punctate inner choroidopathy.
Results
15 patients (22 eyes) were diagnosed as having PIC after underlying systemic disease/infectious causes excluded. Fourteen females and 1 male. Average age was 35.8 years. Seven patients had bilateral involvement (4 of these became bilateral during follow-up) and 73.3% had choroidal neovascularization. For those with CNV the presenting and final visual acuity (VA) ranged from 6/6 to hand movements. Without CNV the presenting VA ranged from 6/4 to 6/18 and final visual acuity was 6/6 for all patients. Five patients did not require treatment. Six received oral steroids and one azathioprine, 1 patient required both Mycophenolate and Adalimumab for bilateral disease. Six with CNV were treated with Eylea, 4 with Lucentis and one patient received both photodynamic therapy and subsequently Lucentis when anti-VEGF became available.
Conlusions
Patients with PIC are generally young females, bilateral involvement and CNV can complicate the disease process.. Immunosuppressive medication may be needed to control inflammatory lesions. The range of final visual acuity appeared to be worse if the presenting acuity was low and if patients had CNV at presentation. Visual acuity in patients without CNV remained excellent at most recent follow up.
Financial Disclosure
The Authors declare no conflict of interest.
Comments
Affilations: Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, Northern Ireland Conflict of Interest: The Authors declare no conflict of interest.